BIOMARIN PHARMACEUTICAL INC - BMRN
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Oct 01, 2026 | EVP, Chief R&D Officer | F | D | 4,086.0 | 60.0 | 245,160.0 | 47,732.0 | View | |
| Sep 14, 2026 | — | A | A | 6,140.0 | 0.0 | 0.0 | 6,140.0 | View | |
| Sep 03, 2026 | EVP, Chief Legal Officer | S | D | 17,557.0 | 66.284 | 1,163,748.19 | 61,003.0 | View | |
| Jun 04, 2026 | — | A | A | 7,490.0 | 0.0 | 0.0 | 21,040.0 | View | |
| Jun 04, 2026 | — | A | A | 7,490.0 | 0.0 | 0.0 | 17,270.0 | View | |
| Jun 04, 2026 | — | A | A | 7,490.0 | 0.0 | 0.0 | 35,500.0 | View | |
| Jun 04, 2026 | — | A | A | 7,490.0 | 0.0 | 0.0 | 49,360.0 | View | |
| Jun 04, 2026 | — | A | A | 7,490.0 | 0.0 | 0.0 | 21,040.0 | View | |
| Jun 04, 2026 | — | A | A | 7,490.0 | 0.0 | 0.0 | 46,440.0 | View | |
| Jun 04, 2026 | — | A | A | 7,490.0 | 0.0 | 0.0 | 14,490.0 | View | |
| Jun 04, 2026 | — | A | A | 7,490.0 | 0.0 | 0.0 | 21,045.0 | View | |
| Jun 04, 2026 | — | A | A | 7,490.0 | 0.0 | 0.0 | 41,940.0 | View | |
| May 21, 2026 | EVP, Chief Commercial Officer | F | D | 2,318.0 | 50.2 | 116,363.6 | 42,472.0 | View | |
| May 11, 2026 | EVP, Chief R&D Officer | S | D | 3,281.0 | 53.85 | 176,681.85 | 51,818.0 | View |